Before a drug ever reaches a patient in a clinical trial, it must pass through a network of tightly connected processes – from raw material procurement to quality assurance and regulatory documentation – different stakeholders. Each stakeholder along this chain faces unique operational and strategic challenges that can disrupt timelines and compromise trial readiness, such as: